Jon Congleton - 11 Nov 2025 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MLYS
Reported as of: 11 Nov 2025
Net transaction value: -$9,088,499
SEC form: 4
Accepted by SEC: 13 Nov 2025, 19:01:30 UTC
Prior SEC filing: 15 Oct 2025
Next SEC filing: 24 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Adam Levy, Attorney-in-fact

Filing notes and source

Key filing fact

Jon Congleton filed Form 4 for Mineralys Therapeutics, Inc. (MLYS) on 13 Nov 2025.

Key facts

This page summarizes Jon Congleton's Form 4 filing for Mineralys Therapeutics, Inc. (MLYS).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Nov 2025, 19:01.

Change

Previous filing in this sequence was filed on 15 Oct 2025.
Current net transaction value: -$9,088,499.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001644975 Primary reporting owner

Congleton Jon

Relationship: Chief Executive Officer, Director
Address: 150 N. RADNOR CHESTER ROAD,, SUITE F200, RADNOR
Signature: /s/ Adam Levy, Attorney-in-fact
Signature date: 13 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MLYS transaction

Common Stock

Sale

Transaction value: $533,235
Shares: -12,806
Change %: -1.5%
Price: $41.64
Shares after: 818,499
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F1

MLYS transaction

Common Stock

Sale

Transaction value: $374,947
Shares: -8,862
Change %: -1.1%
Price: $42.31
Shares after: 809,637
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F2

MLYS transaction

Common Stock

Sale

Transaction value: $173,984
Shares: -4,000
Change %: -0.49%
Price: $43.50
Shares after: 805,637
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F3

MLYS transaction

Common Stock

Sale

Transaction value: $1,320,165
Shares: -29,207
Change %: -3.6%
Price: $45.20
Shares after: 776,430
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F4

MLYS transaction

Common Stock

Sale

Transaction value: $5,145,956
Shares: -112,275
Change %: -14%
Price: $45.83
Shares after: 664,155
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F5

MLYS transaction

Common Stock

Sale

Transaction value: $1,540,212
Shares: -32,850
Change %: -4.9%
Price: $46.89
Shares after: 631,305
Date: 11 Nov 2025
Ownership: Direct
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0500 to $42.0000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Footnote F2

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.0500 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Footnote F3

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Footnote F4

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4800 to $45.4297. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Footnote F5

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4300 to $46.4200. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.

Footnote F6

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4400 to $47.4191. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4.